Relevancy of drug loading to liposomal formulation therapeutic efficacy

被引：118

作者：

Barenholz, Y ^{[1
]}

机构：

[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Membrane & Liposome Res, IL-91010 Jerusalem, Israel

来源：

JOURNAL OF LIPOSOME RESEARCH | 2003年 / 13卷 / 01期

关键词：

D O I：

10.1081/LPR-120017482

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1 / 8

页数：8

共 25 条

[1] [Anonymous], ENCY PHARM TECHNOLOG
[2] A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice
Babai, I
Samira, S
Barenholz, Y
Zakay-Rones, Z
Kedar, E
[J]. VACCINE, 1999, 17 (9-10) : 1223 - 1238
[3] A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice
Babai, I
Samira, S
Barenholz, Y
Zakay-Rones, Z
Kedar, E
[J]. VACCINE, 1999, 17 (9-10) : 1239 - 1250
[4] A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains
Babai, I
Barenholz, Y
Zakay-Rones, Z
Greenbaum, E
Samira, S
Hayon, I
Rochman, M
Kedar, E
[J]. VACCINE, 2001, 20 (3-4) : 505 - 515
[5] Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models
Bandak, S
Goren, D
Horowitz, A
Tzemach, D
Gabizon, A
[J]. ANTI-CANCER DRUGS, 1999, 10 (10) : 911 - 920
[6] Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171
[7] Liposome application: problems and prospects
Barenholz, Y
[J]. CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2001, 6 (01) : 66 - 77
[8] Barenholz Y, 1998, MEDICAL APPLICATIONS OF LIPOSOMES, P545, DOI 10.1016/B978-044482917-7/50031-4
[9] Barenholz Yechezkel, 1995, Journal of Liposome Research, V5, P905, DOI 10.3109/08982109509012690
[10] GABIZON A, 1994, CANCER RES, V54, P987

← 1 2 3 →